Fresenius Kabi Compounding, LLC FDA Record
- Latest inspection OAI · Nov 5, 2025
- Last warning letter 2026
Fresenius Kabi Compounding, LLC has 15 FDA recalls, 3 inspections, 0 510(k) clearances and 1 compliance action on record. FDA has issued 1 warning letter to Fresenius Kabi Compounding, LLC, the most recent on May 12, 2026. FDA has published 1 Form 483 for Fresenius Kabi Compounding, LLC.
- Latest recall
- D-0337-2026 · Class II · Feb 5, 2026
- Latest inspection
- Nov 5, 2025 · OAI
Summary
| Records | Count | Last refreshed | Source as of | Status |
|---|---|---|---|---|
| Recalls | 15 | Nov 15, 2026 | File dated Nov 10, 2026 | Current |
| 510(k) clearances | 0 | Nov 15, 2026 | File dated Nov 9, 2026 | Current |
| Inspections | 3 | Nov 17, 2026 | Newest record Nov 9, 2026 | Current |
| Compliance actions | 1 | Nov 2, 2026 | Newest record Oct 29, 2026 | Current |
FDA record by year
Fresenius Kabi Compounding, LLC: FDA inspections per year
| Year | Inspections | OAI | Warning letters | Recall records | Class I |
|---|---|---|---|---|---|
| 2026 | 0 | 0 | 1 | 5 | 0 |
| 2025 | 1 | 1 | 0 | 0 | 0 |
| 2024 | 0 | 0 | 0 | 10 | 0 |
| 2023 | 1 | 0 | 0 | 0 | 0 |
| 2022 | 0 | 0 | 0 | 0 | 0 |
| 2021 | 0 | 0 | 0 | 0 | 0 |
| 2020 | 0 | 0 | 0 | 0 | 0 |
| 2019 | 0 | 0 | 0 | 0 | 0 |
| 2018 | 1 | 0 | 0 | 0 | 0 |
| 2017 | 0 | 0 | 0 | 0 | 0 |
Reviewing Fresenius Kabi Compounding, LLC as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.
Or check Fresenius Kabi Compounding, LLC yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.
Fresenius Kabi Compounding, LLC FDA Warning Letters
| Issued | Subject | Issuing office | Close-out letter |
|---|---|---|---|
| May 12, 2026 · Record page |
Fresenius Kabi Compounding, LLC Form 483s
| Date | Document | FEI |
|---|---|---|
| Nov 5, 2025 · Document on fda.gov | 483 | 3013438665 |
Recent recalls
| Number | Class | Product | Date |
|---|---|---|---|
| D-0337-2026 | Class II | vancomycin HCl, 2 grams, 2 grams added to 500 mL, 0.9% Sodium Chloride Injection, USP, Fagron… | Feb 5, 2026 |
| D-0334-2026 | Class II | ketamine HCl, 1,000 mg, 1,000 mg per 100 mL (10 mg per mL) in Sodium Chloride Injection, Fagron… | Feb 5, 2026 |
| D-0335-2026 | Class II | thiamine HCl, 500 mg, 500 mg added to 100 mL, 0.9% Sodium Chloride Injection, USP, Fagron Sterile… | Feb 5, 2026 |
| D-0333-2026 | Class II | acyclovir sodium, 200 mg, 200mg added to 100 mL, 0.9% Sodium Chloride Injection, USP, For… | Feb 5, 2026 |
| D-0336-2026 | Class II | vancomycin HCl, 1.5 grams, 1.5 grams added to 500 mL, 0.9% Sodium Chloride Injection, USP, Fagron… | Feb 5, 2026 |
| D-0017-2025 | Class II | Phenylephrine HCl 0.9% Sodium Chloride Injection USP, 10 mg per 250 mL, Single Dose Bag, Rx only… | Sep 25, 2024 |
| D-0021-2025 | Class II | Oxytocin 0.9% Sodium Chloride Injection USP, 30 units per 500 mL Single Dose Bag, Rx only, Fagron… | Sep 25, 2024 |
| D-0014-2025 | Class II | Phenylephrine HCl 0.9% Sodium Chloride Injection USP, 20 mg per 250 mL, Single Dose Bag, Rx only… | Sep 25, 2024 |
| D-0018-2025 | Class II | Vancomycin HCl 750 mg per 250 mL 0.9% Sodium Chloride Injection USP, Single Dose Bag, Rx only… | Sep 25, 2024 |
| D-0023-2025 | Class II | Thiamine HCl 0.9% Sodium Chloride Injection USP, 500 mg per 100 mL, Single Dose Bag, Rx only, Fagron… | Sep 25, 2024 |
| D-0022-2025 | Class II | EPINEPHrine 0.9% Sodium Chloride Injection USP, 8 mg per 250 mL Single Dose Bag, Rx only, Fagron… | Sep 25, 2024 |
| D-0016-2025 | Class II | Phenylephrine HCl 0.9% Sodium Chloride Injection USP, 10 mg per 250 mL, Single Dose Bag, Rx only… | Sep 25, 2024 |
| D-0019-2025 | Class II | NORepinephrine Bitartrate 0.9% Sodium Chloride Injection USP, 4 mg per 250 mL, Single Dose Bag, Rx… | Sep 25, 2024 |
| D-0015-2025 | Class II | Phenylephrine HCl 0.9% Sodium Chloride Injection USP, 20 mg per 250 mL, Single Dose Bag, Rx only… | Sep 25, 2024 |
| D-0020-2025 | Class II | NORepinephrine Bitartrate 0.9% Sodium Chloride Injection USP, 8 mg per 250 mL, Single Dose Bag, Rx… | Sep 25, 2024 |
Recent FDA inspections
| Date | Site | Product | Classification | FEI |
|---|---|---|---|---|
| Nov 5, 2025 | Canton, MA | Drugs | Official Action Indicated (OAI) | 3013438665 |
| Mar 6, 2023 | Canton, MA | Drugs | Voluntary Action Indicated (VAI) | 3013438665 |
| Dec 4, 2018 | Canton, MA | Drugs | Voluntary Action Indicated (VAI) | 3013438665 |
- NAI
- No objectionable conditions or practices were found during the inspection.
- VAI
- Objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action.
- OAI
- Regulatory and/or administrative actions are recommended.
Compliance Actions
FDA's compliance actions data lists 1 compliance action under Fresenius Kabi Compounding, LLC: warning letters, injunctions and seizures. None came from FDA's Center for Tobacco Products.
FDA-inspected facilities
| Facility | Location | Inspections | Latest |
|---|---|---|---|
| FEI 3013438665 | Canton, MA | 3 | Nov 5, 2025 |
Fresenius Kabi Compounding, LLC and the FDA: common questions
Has Fresenius Kabi Compounding, LLC received an FDA warning letter?
Yes. FDA has issued 1 warning letter to Fresenius Kabi Compounding, LLC. The most recent is dated May 12, 2026.
Has Fresenius Kabi Compounding, LLC received an FDA Form 483?
FDA has published 1 Form 483 for Fresenius Kabi Compounding, LLC in its reading room, the most recent dated Nov 5, 2025. FDA publishes some Form 483s, not all of them.
When did the FDA last inspect Fresenius Kabi Compounding, LLC?
The most recent FDA inspection on file ended Nov 5, 2025 at Canton, MA and was classified OAI. FDA has 3 inspections of Fresenius Kabi Compounding, LLC on file, 1 of them classified OAI (official action indicated).
Has Fresenius Kabi Compounding, LLC had an FDA recall?
Yes. Fresenius Kabi Compounding, LLC has 15 FDA recalls on record. The most recent started Feb 5, 2026.
Need more than this page shows? Ask about Fresenius Kabi Compounding, LLC in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.